New Products

BASF’s Personal Care Business Obtains Cosmetic Ingredient Notification for Active Ingredient in China

Symbiocell is proven through in vitro tests to support healthy levels of the basal expression of CD86 in skin dendritic cells.

Author Image

By: Lianna Albrizio

Associate Editor

BASF’s Personal Care business has obtained a new cosmetic ingredient notification for Symbiocell, which can be commercialized as a cosmetic ingredient with BASF’s authorization in China.

Symbiocell (INCI: Water (and) Butylene Glycol (and) Cestrum Latifolium Leaf Extract (and) Xanthan Gum (and) Propanediol (and) Caprylyl Glycol), is proven through in vitro tests to support healthy levels of the basal expression of CD86 in skin dendritic cells. It effectively soothes sensitive skin and potentially excessive cutaneous reactions.

The key component of Symbiocell, Cestrum latifolium, is known in tropical regions for its healing properties and has known applications for a variety of skin issues, officials said. Inspired by these properties, BASF has clinically tested a face care formulation with 2% Symbiocell and demonstrated that it reduces the level of reactivity and discomfort in sensitive skin. The ingredient was developed in response to a growing consumer trend for cosmetic products that address common sensitive skin concerns, with Asia Pacific being the key region in focus.

Clinically Results

A double-blind clinical study was conducted on 31 women to compare the efficacy of a 2% concentration of Symbiocell in a face care formulation to that of a commercially available soothing, anti-redness skin care product over a three-week application period.

The results showed that cutaneous discomfort that was previously observed during a stinging test conducted on the side of the face treated with Symbiocell at 2% significantly diminished by 62%, while the average decrease for the side of the face treated with the benchmark product was 58%. Moreover, the side of the face to which Symbiocell (2%) was applied daily showed a significant decrease of 20% in the mean score of the stinging test. The other side of the face, to which the benchmark product was applied, only showed a decrease of 14%.

According to 97% of the volunteers, the side of the face treated with Symbiocell felt increasingly comforted and soothed. Among the panelists, 90% stated their skin was less irritable and 87% felt that their skin is better prepared against external aggressors.

Seventy-one percent of volunteers tested have also felt their skin was more radiant.

Keep Up With Our Content. Subscribe To Happi Newsletters